NASDAQ: ODD · ODDITY Tech Ltd.Enhanced Equity Research · June 29, 2026
Equity Research Report
Analysis by Joseph Lefcoe
Enhanced Equity Research — ODDITY Tech Ltd. (ODD)
AI-Powered DTC Beauty PlatformPost-Shock Deep ValueBroken Growth, Intact Balance Sheet

ODD

ODDITY Tech Ltd. — Enhanced Equity Research
Current Price
$13.07
Market Cap
$745M
52-Week High
$77.83
52-Week Low
$9.25
HOLD
PT $16
+22% upside · Medium conviction

AI-beauty compounder hit by an ad-platform shock — broken stock, intact balance sheet, no guidance

ODDITY Tech (ODD) spent two years as the rare profitable, fast-growing DTC beauty platform — FY2025 net revenue rose 25% to $810M at a ~72.5% gross margin with ~$2.10+ adjusted EPS — but the stock has collapsed ~83% from a $79 high to roughly $13 (market cap ~$745M). The break came in Q1'26: a technical algorithm change at ODDITY's largest advertising partner pushed spend into low-quality auctions, spiking customer-acquisition cost (CPA) at flagship IL MAKIAGE. Revenue fell 26% to $197.9M, the company swung to a −$21.4M net loss (adj. EPS −$0.17 vs ~−$0.04 est.), adjusted EBITDA went to −$7M, and management suspended FY2026 guidance — guiding only Q2 revenue down 25–30% with adj. EBITDA back to $8–10M positive. The balance sheet is the bull's anchor: $667M cash + investments, no debt, and an active $200M buyback ($82M repurchased in Q1, cutting Class A shares ~10.6%). Sell-side turned sharply negative — Goldman cut to Sell ($8), Barclays Underweight ($8), BofA Underperform ($8.50), Morgan Stanley Equal Weight ($10) — with the average PT down ~71% in 90 days. The debate is binary: a fixable platform glitch on a structurally advantaged tech platform, or evidence that the AI/data "moat" was really paid-acquisition arbitrage. We rate HOLD — the valuation has reset toward beauty-peer levels, but with no guidance and an unproven fix, conviction stays Medium until the Q2 print confirms normalization.

Software-like margins, suddenly broken growth engine — FY2025 was a record (+25% to $810M, ~72.5% gross margin), but a Q1'26 ad-algorithm shock at IL MAKIAGE spiked customer-acquisition cost, cut revenue 26% and forced management to suspend FY2026 guidance.

FY2025 Revenue
$810.0M
+25% YoY, beat guidance
Q1'26 Revenue
$197.9M
−26% YoY (ad-CPA shock)
Q1'26 Gross Margin
69.7%
−520 bps YoY
Q1'26 Net Loss (GAAP)
−$21.4M
vs +$37.8M Q1'25
Cash & Investments
$667M
No debt; $278.6M cash equiv.
Adj. EPS Q1'26
−$0.17
Missed ~−$0.04 est.
Buyback Authorized
$200M
$82M done Q1; $167M left
FY2026 Guidance
Suspended
Q2 rev −25/−30%; EBITDA +$8–10M

Quarterly Revenue — Trailing 4 Quarters

$194M
Q2 2025
$203M
Q3 2025
$159M
Q4 2025
$197.9M
Q1 2026

The growth engine stalled — recovery hinges on fixing CPA and proving the platform, not the ad budget

−26%
Q1'26 Revenue Growth
First-ever YoY decline
40M+
Proprietary Customer Dataset
Powers AI product-matching
$667M
Cash & Investments
Funds buyback + brand launches
Feb 2025
Record FY2024 / 2025 Setup
FY2024 revenue $647M (+27%); IL MAKIAGE crossed $500M. ODDITY entered 2025 as a profitable DTC beauty-tech compounder with software-like margins.
Q3 2025
Guidance Raised
Raised FY2025 outlook to ~$806–809M revenue, ~72.5% gross margin, $161–163M adj. EBITDA, $2.10–2.12 adj. EPS — a streak of beat-and-raise quarters.
Mar 2026
$200M Buyback Authorized
Board approved a new $200M Class A repurchase (replacing $150M plan), expiring Mar 2029 — signaling confidence ahead of the Q1 shock.
Jun 2, 2026
Q1'26 Shock & Guidance Suspension
Revenue −26% to $197.9M on an ad-partner algorithm change that spiked CPA at IL MAKIAGE; swung to −$21.4M loss; FY2026 guidance suspended. Stock cratered.
Aug 3, 2026E
Q2'26 Print — Key Catalyst
Q2 guided to revenue −25/−30% but adj. EBITDA back to +$8–10M. The market needs evidence the CPA fix is taking hold and growth can re-accelerate into H2.

Forward Estimates, Surprises & Insider Activity

Forward Earnings Estimates

FY+1 EPS Consensus~$0.07-$0.30 (FY2026E, heavily cut; Goldman trimmed to ~$0.07)
FY+2 EPS Consensus~$0.60-$1.00 (FY2027E, recovery-dependent, est.)
PEG RatioN/A — depressed/uncertain FY2026 EPS and negative current growth make PEG non-meaningful
Forward P/E~13-15x on a recovery FY2027 EPS; FY2026 P/E inflated/n/m on collapsed earnings
EPS Revisions (90d)↑0 ↓11 (Sharply negative — every covering analyst cut 2026/2027 EPS post-Q1; Goldman cut FY2026 to ~$0.07 and average PT fell ~71% in 90 days)
Guidance AccuracyStrong multi-year beat-and-raise track record through 2025, then a sharp break — FY2026 guidance suspended entirely after the Q1 ad-platform shock

Earnings Surprise Track Record

Q1 2026 Est: ~−$0.04 (adj.) Act: −$0.17 (adj.) Missed by ~$0.13 / ~325%
Q4 2025 Est: ~$0.18 Act: $0.20 Beat
Q3 2025 Est: in-line/beat Act: raised FY outlook Beat + raise
Q2 2025 Est: in-line/beat Act: beat Beat
Beat RateBeat 3 of the last 4 quarters; the Q1'26 miss was severe (~325% below) and broke a long beat-and-raise streak

Insider Activity (90 Days)

Net Buying/Selling$0 reported open-market insider purchases; company-level buyback ~$82M in Q1'26
Sell/Buy RatioN/A at the individual-insider level — Class B founders are not transacting in the open market; the dominant signal is the corporate buyback
Mixed-to-constructive. There is no notable open-market individual insider buying to flag conviction, but the company itself is an aggressive repurchaser ($82M in Q1, $167M remaining), which functions as a corporate vote of confidence at ~$13. Founder Class B control means insider economic alignment is high even without recent open-market trades.
The most material capital signal is corporate, not personal: a $200M buyback authorization (Mar 2026) with ~10.6% of Class A shares retired in Q1'26 alone. No disclosed insider sells; founder/CEO Oran Holtzman retains super-voting control.

Relative Valuation vs. Competitors

CompanyP/EEV/RevRev GrowthGross Margin
ODDITY Tech~12x~0.7x−26% (Q1'26)~70%
e.l.f. Beauty~40x~5x~+10-15%~70%
Coty~15x~1.8x~low-single~65%
Estee Lauder~30x~2.5x~flat/neg~72%
ODDITY's collapse has re-rated it from a tech-style multiple (it once carried ~6.7x EV/Revenue and ~43x EV/EBITDA) all the way down to roughly beauty-staple — or lower — territory: ~0.7x EV/Revenue and ~12x trailing earnings, far below ELF (~5x EV/Rev, ~40x P/E) and even discount/turnaround names like Coty. The market is now pricing ODD closer to a structurally challenged DTC retailer than the high-margin software-like compounder it traded as in 2024-2025. Its ~70% gross margin still rivals premium peers, but the negative top-line growth and suspended guidance justify the discount until CPA normalizes. The bull case is mean-reversion: if the platform thesis holds, the gap to ELF is enormous.

Price Targets & Scenarios

ScenarioPrice TargetAssumptionsProbability
Glitch Fixed, Platform Re-rates$26CPA normalizes by H2'26, IL MAKIAGE re-accelerates, Brand 3/medical launches land, and the AI/data platform thesis (vs. pure ad arbitrage) is vindicated. Revenue returns to double-digit growth in 2027, EBITDA margin rebuilds toward high-teens, and the stock re-rates toward a tech-DTC multiple off a washed-out base.30%
Slow Normalization, Beauty Multiple$14CPA pressure eases gradually; FY2026 revenue still down meaningfully YoY but adj. EBITDA stays positive. Growth resumes in 2027 at a slower, more discount-retailer pace. Buyback supports the float. Stock trades as a consumer-staples beauty name near current levels, not a software multiple.45%
Moat Was Ad Arbitrage$8The 'AI moat' proves to have been paid-acquisition dependent; CPA pressure persists or competition (ELF, TikTok-native brands) compounds it. Growth stays negative through 2026, EBITDA disappoints, and the stock converges to the cluster of Sell/Underweight $8 targets — a low-growth beauty company with eroding unit economics.25%

Probability-Weighted Target: $16 (~22% upside vs $13.07)

$16
Weighted
Bull $2630%
Base $1445%
Bear $825%

Analyst Consensus

Goldman Sachs
$8
Downgraded to Sell
Barclays
$8
Underweight
BofA
$8.50
Underperform
Morgan Stanley
$10
Equal Weight
Consensus reset to roughly Hold after Q1'26. The average 12-month PT collapsed ~71% in 90 days into the low-teens (range ~$8 low end to ~$18 high), with Goldman (Sell, $8), Barclays (Underweight, $8) and BofA (Underperform, $8.50) clustered near the bottom and a handful of bulls still arguing the platform thesis. Sentiment is firmly wait-and-see pending Q2.

Key Levels & Options Intelligence

S/RSupport & Resistance

52-Week High (Jun 2025)
$77.83
200-Day Moving Avg
$38.81
100-Day Moving Avg
$24.04
50-Day Moving Avg
$14.26
Near-Term Resistance
$13.98
Current Price (Jun 20, 2026)
$13.07
Support / Recent Floor
$10.25
52-Week / All-Time Low (Jun 3)
$9.25

OptOptions & Sentiment

  • RSI (14-day): ~37.5 — approaching oversold; reflects the post-Q1 downtrend, bias bearish/neutral
  • Moving-Average Signal: Strong Sell — price below all major MAs (50d $14.26, 100d $24.04, 200d $38.81); ~64% below the 200-day
  • Beta: ~1.9 to ~3.3 (source-dependent) — elevated; trades as a high-volatility, headline-sensitive DTC name
  • Short Interest: ~4.43M shares · ~7.94% of float — meaningful skepticism, some squeeze potential on a positive Q2
  • Support / Resistance: Support $10.25 (with intermediate $11.52 / $12.46); resistance $13.98 then the $14.26 50-day MA
  • Implied Volatility: Elevated post-shock; options data thin — expect outsized moves around the Aug 3 Q2 print
  • Drawdown from Peak: −83% from the $77.83 52-week high to ~$13 on the CPA shock and guidance suspension
  • Realized Volatility: Double-digit intraday swings common since Q1; the stock has not yet found a stable post-shock range

Systematic Conviction Score: 47/100 (Low)

35
Analyst Alignment
30%
25
FCF Visibility
25%
55
Catalyst Clarity
20%
75
Valuation Safety
15%
60
Mgmt Quality
10%
Sell-side turned negative-to-neutral with a cluster of Sell/Underweight $8 targets (analyst alignment 35), and suspended FY2026 guidance with a Q1 loss leaves FCF/earnings visibility weak (25). The offsets are a deeply reset valuation versus ~$667M net cash and an active buyback (valuation safety 75) and a credible founder-led team with a strong pre-shock track record (60). The weighted score of 47 lands Low — a HOLD that is really a 'prove-it' value setup hinging on the Q2 print.

Risk Assessment & Insider Signals

!Risk Factors

  • Advertising-Platform Dependence (CPA Shock): A single technical algorithm change at ODDITY's largest ad partner spiked customer-acquisition cost, cut Q1'26 revenue 26% and erased profitability. The episode exposes deep dependence on third-party ad platforms for new-customer flow. If CPA stays elevated or the partner relationship deteriorates, the core growth engine remains impaired — and it calls into question whether the 'AI moat' is durable or just efficient ad arbitrage.
  • No FY2026 Guidance / Low Visibility: Management suspended full-year 2026 guidance, citing limited P&L visibility beyond a positive adj. EBITDA. Investors are flying blind on revenue, margin and EPS trajectory until at least the Q2 print, which structurally caps the multiple and amplifies volatility around each report.
  • Moat Skepticism vs. Beauty Competition: Bears argue ODDITY's data/AI advantage was overstated and its real edge was paid acquisition. Meanwhile ELF, TikTok-native brands and incumbents (Coty, Estee Lauder) intensify competition for the same online beauty consumer. If the platform can't reaccelerate organically, ODD converges to a low-growth beauty multiple.
  • Profitability & Cash Burn in 2026: The company swung to a −$21.4M net loss and −$7M adj. EBITDA in Q1'26, with −$21M free cash flow. While $667M cash and a no-debt balance sheet provide ample runway, a prolonged CPA problem could keep EBITDA depressed and pressure the buyback pace and the stock's value-support thesis.
  • Dual-Class / Governance Concentration: Co-founder/CEO Oran Holtzman controls super-voting Class B shares (10 votes each), giving founders entrenched control with effectively 0% Class A 'insider' float. Public Class A holders have minimal governance leverage, and capital-allocation or strategic decisions rest with insiders regardless of public-shareholder sentiment.
  • Execution Risk on New Brand / Telehealth Launches: ODDITY's longer-term growth case depends on launching new brands (Brand 3, medical/telehealth) on top of IL MAKIAGE and SpoiledChild. Doing so while the core brand's acquisition economics are broken raises execution risk; launch slippage or weak adoption would remove the offsetting growth narrative.

OOwnership & Insider Signals

  • Institutional Ownership: ~81% of shares are held by ~356 institutions. Baillie Gifford is the largest holder at ~6.05M shares (~10.5% of Class A), reflecting a growth-investor base that bought the long-duration platform story.
  • Quarterly Institutional Flow: Net selling last quarter — institutions bought ~38.8M shares but sold ~46.8M, a net reduction consistent with the post-Q1 de-rating and PT cuts across the sell-side.
  • Founder / CEO Control (Class B): Co-founder & CEO Oran Holtzman holds super-voting Class B shares (10 votes each), concentrating voting control with the founding team. Reported Class A 'insider' ownership shows ~0%, an artifact of the dual-class structure.
  • Retail Ownership: ~18.65% retail — an elevated retail base for a beaten-down DTC name, which adds to headline-driven volatility around earnings.
  • Buyback as Ownership Lever: The $200M Class A repurchase (with $82M executed in Q1'26, cutting Class A shares ~10.6%) is actively shrinking the public float and is central to the value-support thesis at depressed prices.
  • No Lockup Overhang: As a 2023 IPO, ODDITY has no lockup-expiration overhang; the share-count dynamic is now driven by buybacks reducing supply rather than insider unlocks adding it.

Quantified Risk Assessment

Severity Risk Factor Prob. PT Impact
High Advertising-Platform Dependence (CPA Shock) 55% -30%
High No FY2026 Guidance / Low Visibility 60% -20%
High Moat Skepticism vs. Beauty Competition 45% -25%
Medium Profitability & Cash Burn in 2026 40% -15%
Medium Dual-Class / Governance Concentration 35% -10%
Low Execution Risk on New Brand / Telehealth Launches 30% -10%

Summary

Rating
HOLD
Conviction
Medium
Price Target
$16
Timeframe
12 mo
Upside
+22%
Position Size
1.5%-2.5%

Entry Strategy

1
Tranche 1 — 35%
~$12.50
Starter near current price, below the $13.98 resistance / $14.26 50-day MA. Keep total weight small (1.5%-2.5%) given suspended guidance and binary outcome risk.
2
Tranche 2 — 35%
~$10.25
Add at the established support floor. This is the value zone where ~$667M cash + buyback provide a tangible backstop relative to the ~$745M market cap.
3
Tranche 3 — 30%
~$9.25
Final tranche reserved for a retest of the all-time low, likely on a second disappointment or a weak Q2 — maximum-pessimism entry near the Sell/Underweight $8 cluster.
IMPORTANT DISCLAIMER: This analysis is for educational and research purposes only. Not financial advice. Past performance does not guarantee future results. Consult qualified financial professionals before making investment decisions. All investments carry risk of loss. The information presented is based on publicly available data as of June 29, 2026.